Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.

Rubinstein, Ethan; Isturiz, Raul; Standiford, Harold C; Smith, Leon G; Oliphant, Thomas H; Cammarata, Sue; Hafkin, Barry; Le, Vu; Remington, Jack

Rubinstein, Ethan; Isturiz, Raul; Standiford, Harold C; Smith, Leon G; Oliphant, Thomas H; Cammarata, Sue; Hafkin, Barry; Le, Vu; Remington, Jack.

Affiliation

Rubinstein E; The Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel-Hashomer, Israel. erubins@yahoo.com

Antimicrob Agents Chemother ; 47(6): 1824-31, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12760854

Subject(s)

Acetamides/adverse effects; Anti-Infective Agents/adverse effects; Gram-Positive Bacterial Infections/drug therapy; Oxazolidinones/adverse effects; Protein Synthesis Inhibitors/adverse effects; Acetamides/therapeutic use; Adolescent; Adult; Aged; Anti-Infective Agents/therapeutic use; Clinical Trials, Phase III as Topic; Community-Acquired Infections/drug therapy; Cross Infection/drug therapy; Drug Interactions; Female; Humans; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Oxazolidinones/therapeutic use; Protein Synthesis Inhibitors/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Synthesis Inhibitors / Gram-Positive Bacterial Infections / Oxazolidinones / Acetamides / Anti-Infective Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2003 Type: Article Affiliation country: Israel

Fulltext

XML

PubMed Links

Search on Google